Open AccessEffects of venlafaxine on gastrointestinal symptoms, depression, anxiety, stress, and quality of life in patients with the moderate-to-severe irritable bowel syndrome
Author(s) -
Mohammad Reza Sharbafchi,
Hamid Afshar,
Pardis Adhamian,
Awat Feizi,
Hamed Daghaghzadeh,
Peyman Adibi
Publication year - 2020
Publication title -
journal of research in medical sciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.568
H-Index - 39
eISSN - 1735-7136
pISSN - 1735-1995
DOI - 10.4103/jrms.jrms_699_19
Subject(s) - medicine , irritable bowel syndrome , venlafaxine , placebo , anxiety , nausea , quality of life (healthcare) , depression (economics) , discontinuation , randomization , randomized controlled trial , psychiatry , antidepressant , alternative medicine , nursing , macroeconomics , pathology , economics